Vortioxetine Set For Japan Filing But Prospects Limited?

Positive results from a Japanese trial of Takeda/Lundbeck’s vortioxetine pave way for a planned approval filing in the country this year, but how might drug fare in the market?

nerve cells, concept for neurodegenerative and neurological disease
VORTIOXETINE EDGES TOWARDS JAPAN FILING • Source: Shutterstock

More from Japan

More from Focus On Asia